Author Correction: Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial.
Kirkwood JM, Del Vecchio M, Weber J, Hoeller C, Grob JJ, Mohr P, Loquai C, Dutriaux C, Chiarion-Sileni V, Mackiewicz J, Rutkowski P, Arenberger P, Quereux G, Meniawy TM, Ascierto PA, Menzies AM, Durani P, Lobo M, Campigotto F, Gastman B, Long GV.
Kirkwood JM, et al. Among authors: dutriaux c.
Nat Med. 2024 Mar;30(3):906. doi: 10.1038/s41591-023-02775-w.
Nat Med. 2024.
PMID: 38177857
Free PMC article.
No abstract available.